Sign in
Explore the registryTrack Alxn2030's trials

CONCORD

Phase 2 Study of ALXN2030 in Patients With Antibody-Mediated Rejection After Kidney Transplantation

ALXN2030OngoingActive not recruitingPhase 2Open NCT06744647 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…